IFATS Recommendations for FDA Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products

International Federation of Adipose Therapeutics and Sciences (IFATS) 45 Lyme Road – Suite 304 Hanover, NH 03755 USA Tel: 1-603-643-2325, Fax: 1-603-643-1444   September 26, 2016   Division of Dockets Management (HFA–305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852   Re: FDA-2014-D-1856 – Comments to 2014-2015 Draft Guidance regarding: Docket

Scientists Confirm Reprogrammed Adult Stem Cells Identical to Embryonic Stem Cells

Click on photo (at left) to enlarge Photo: iPS cells feature – reprogrammed stem cells: Credit: Moscow Institute of Physics and Technology Russian researchers have concluded that reprogramming does not create differences between reprogrammed and embryonic stem cells. Stem cells are specialized, undifferentiated cells that can divide and have the remarkable potential to develop into many different cell

Purest Liver-like Cells to Date Generated from Induced Pluripotent Stem Cells (iPSCs)

liver stem cell research

Researchers from the Medical University of South Carolina (MUSC) and the University of Pennsylvania have discovered a new methodology for purifying liver cells generated from induced pluripotent stem cells (iPSCs) that could facilitate progress toward an important clinical goal: treating patients with disease-causing liver mutations by transplanting unmutated liver cells derived from their own stem

The Language of Stem Cell Medicine: What are They? What Makes Them so Special? And What do all Those Acronyms Mean?

stem cell medicine

Stem cell medicine is based on the concept that physicians can harness the body’s own reserves to heal itself, rather than relying exclusively on drugs or invasive surgical procedures. Stem cell medicine works by deals engineering human stem cells to replace or restore damaged or diseased organs or tissue, or establish normal function in them. While

Adipose Stem Cell Therapies are Revolutionizing Plastic Surgery, and Demand is High

adipose stem cell therapies

Adipose stem cells (pictured) harvested from body fat. (Photo: Genetic Engineering & Biotechnology News). The discovery of abundant stem cell populations in body fat tissue changed everything the medical community thought it knew about stem cells overnight. Now, adipose stem cell therapies are driving the plastic and cosmetic surgery industries, and demand among patients keeps

Stem Cell Research Goes Crimson: International Leader in Stem Cell Research Named New Dean of Harvard Medical School

Harvard medical

George Q. Daley, MD, PhD, Harvard Medical School’s newly appointed dean, led dozens of international colleagues in developing ethical guidelines for stem cell research. On March 9, 2009, President Barack H. Obama issued Executive Order 13505: Removing Barriers to Responsible Scientific Research involving Human Stem Cells, stating that the Secretary of Health and Human Services, through

Texas Man Becomes First Adult in the U.S. to Receive Updated Stem Cell Transplant to Treat Leukemia

stem cell transplant

Chuck Dandridge, a Mansfield, Texas resident, became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member. The milestone was announced by researchers at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center in Dallas, where the procedure was performed.

Insulin-producing Stem Cells Grown in the Lab Mark a New Era in Stem Cell Therapies for Diabetes

insulin-producing pancreatic beta cells

A new discovery by researchers on how to activate lab-grown beta cells to mature into functioning cells that produce and release insulin in response to glucose take a significant step toward a cell therapy treatment for diabetes. Difficulties in manipulating beta cells derived from human stem cells to mature beyond the precursor stage into fully